niceritrol has been researched along with Alloxan Diabetes in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hotta, N | 1 |
| Kakuta, H | 1 |
| Fukasawa, H | 1 |
| Koh, N | 1 |
| Sakakibara, F | 1 |
| Komori, H | 1 |
| Sakamoto, N | 1 |
1 other study available for niceritrol and Alloxan Diabetes
| Article | Year |
|---|---|
Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fructos | 1992 |